Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-09-09

FDA Approved: MIBELAS 24 FE — Supplemental Application (Lupin Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Lupin's supplemental application for MIBELAS 24 FE, a norethindrone acetate/ethinyl estradiol/ferrous fumarate combination oral contraceptive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MIBELAS 24 FE (NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATE)

Snippet

SUPPL AP for MIBELAS 24 FE (NORETHINDRONE ACETATE, ETHINYL ESTRADIOL AND FERROUS FUMARATE)